Vicki L. Ellingrod

4.3k total citations
131 papers, 3.1k citations indexed

About

Vicki L. Ellingrod is a scholar working on Psychiatry and Mental health, Physiology and Pharmacology. According to data from OpenAlex, Vicki L. Ellingrod has authored 131 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Psychiatry and Mental health, 25 papers in Physiology and 24 papers in Pharmacology. Recurrent topics in Vicki L. Ellingrod's work include Schizophrenia research and treatment (35 papers), Pharmacogenetics and Drug Metabolism (24 papers) and Diet and metabolism studies (20 papers). Vicki L. Ellingrod is often cited by papers focused on Schizophrenia research and treatment (35 papers), Pharmacogenetics and Drug Metabolism (24 papers) and Diet and metabolism studies (20 papers). Vicki L. Ellingrod collaborates with scholars based in United States, Canada and China. Vicki L. Ellingrod's co-authors include Del D. Miller, Stephanie A. Flowers, Jeffrey R. Bishop, Kyle J. Burghardt, Kristen M. Ward, Melvin G. McInnis, Timothy L. Holman, Stephan Arndt, Stephan F. Taylor and Simon J. Evans and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Psychiatry.

In The Last Decade

Vicki L. Ellingrod

127 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vicki L. Ellingrod United States 30 1.2k 695 556 391 371 131 3.1k
Francisco J. Díaz United States 36 1.7k 1.4× 699 1.0× 1.4k 2.6× 351 0.9× 427 1.2× 141 4.5k
Winston W. Shen Taiwan 30 1.2k 1.0× 338 0.5× 369 0.7× 237 0.6× 272 0.7× 110 3.1k
Mong‐Liang Lu Taiwan 30 1.2k 1.0× 549 0.8× 547 1.0× 144 0.4× 178 0.5× 128 2.9k
Koichi Otani Japan 31 1.4k 1.1× 507 0.7× 251 0.5× 208 0.5× 497 1.3× 204 3.5k
Norio Yasui‐Furukori Japan 29 1.5k 1.2× 258 0.4× 267 0.5× 212 0.5× 465 1.3× 222 3.0k
Chad Bousman Australia 38 1.1k 0.9× 742 1.1× 312 0.6× 210 0.5× 561 1.5× 188 4.4k
Shih‐Ku Lin Taiwan 31 1.3k 1.1× 413 0.6× 256 0.5× 178 0.5× 172 0.5× 126 3.0k
Susan E. Shoaf United States 31 441 0.4× 777 1.1× 799 1.4× 102 0.3× 315 0.8× 81 3.8k
Steven M. Paul United States 36 484 0.4× 762 1.1× 567 1.0× 402 1.0× 249 0.7× 64 4.9k
William V. Bobo United States 35 1.7k 1.4× 280 0.4× 254 0.5× 733 1.9× 491 1.3× 154 4.4k

Countries citing papers authored by Vicki L. Ellingrod

Since Specialization
Citations

This map shows the geographic impact of Vicki L. Ellingrod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicki L. Ellingrod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicki L. Ellingrod more than expected).

Fields of papers citing papers by Vicki L. Ellingrod

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vicki L. Ellingrod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicki L. Ellingrod. The network helps show where Vicki L. Ellingrod may publish in the future.

Co-authorship network of co-authors of Vicki L. Ellingrod

This figure shows the co-authorship network connecting the top 25 collaborators of Vicki L. Ellingrod. A scholar is included among the top collaborators of Vicki L. Ellingrod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vicki L. Ellingrod. Vicki L. Ellingrod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Duxin, Christian Macedonia, Zhigang Chen, et al.. (2024). Can Machine Learning Overcome the 95% Failure Rate and Reality that Only 30% of Approved Cancer Drugs Meaningfully Extend Patient Survival?. Journal of Medicinal Chemistry. 67(18). 16035–16055. 3 indexed citations
2.
Leung, Jonathan G., et al.. (2023). A systematic review of clozapine‐associated inflammation and related monitoring. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(12). 1364–1396. 25 indexed citations
3.
Ianni, Phillip A., et al.. (2023). A QUASIEXPERIMENTAL EVALUATION OF A CLINICAL RESEARCH TRAINING PROGRAM. Performance Improvement Quarterly. 36(1). 4–13. 2 indexed citations
4.
Eakin, Brenda, et al.. (2022). Reimagining a summer research program during COVID: Strategies for enhancing research workforce diversity. Journal of Clinical and Translational Science. 6(1). 2 indexed citations
5.
Plegue, Melissa, Reema Kadri, Souvik Roy, et al.. (2021). Pharmacogenomic Testing for Mental Health (Part II): Qualitative Analysis of Early Adopter Prescriber Perceptions. Personalized Medicine. 18(3). 233–240. 1 indexed citations
6.
Mills, James A., et al.. (2021). Sexual Functioning in Adolescents With Major Depressive Disorder. The Journal of Clinical Psychiatry. 82(6). 1 indexed citations
7.
Plegue, Melissa, Reema Kadri, Vicki L. Ellingrod, et al.. (2021). Pharmacogenomic Testing for Mental Health (Part I): Documenting Early Adopter Perceptions of Use for Eight Scenarios. Personalized Medicine. 18(3). 223–232. 2 indexed citations
8.
Kadri, Reema, Karen B. Farris, Vicki L. Ellingrod, et al.. (2019). Using Pharmacogenomic Testing in Primary Care: Protocol for a Pilot Randomized Controlled Study. JMIR Research Protocols. 8(8). e13848–e13848. 2 indexed citations
9.
Ellingrod, Vicki L. & Kristen M. Ward. (2018). Using pharmacogenetics guidelines when prescribing: What's available. Current psychiatry. 17(1). 43–46. 2 indexed citations
10.
Anderson, Elizabeth W., et al.. (2018). Implementing and measuring the impact of a clinical and translational research mentor recognition program. Journal of Clinical and Translational Science. 2(5). 312–320. 4 indexed citations
11.
Hicks, J. Kevin, Katrin Sangkuhl, Jesse J. Swen, et al.. (2017). Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update. Data Archiving and Networked Services (DANS). 57 indexed citations
12.
McQueen, Cydney E. & Vicki L. Ellingrod. (2017). Herb-drug interactions: Caution patients when changing supplements. Current psychiatry. 16(6). 38–41. 1 indexed citations
13.
Burghardt, Kyle J., et al.. (2015). An Untargeted Metabolomics Analysis of Antipsychotic Use in Bipolar Disorder. Clinical and Translational Science. 8(5). 432–440. 21 indexed citations
14.
Ellingrod, Vicki L., et al.. (2014). Strategies for managing drug-induced tardive dyskinesia. Current psychiatry. 13(3). 44–46. 1 indexed citations
15.
Bly, Michael J., Jeffrey R. Bishop, Kelan Thomas, & Vicki L. Ellingrod. (2013). P-glycoprotein (PGP) Polymorphisms and Sexual Dysfunction in Female Patients With Depression and SSRI-Associated Sexual Side Effects. Journal of Sex & Marital Therapy. 39(3). 280–288. 18 indexed citations
16.
Lott, Stephen, Paul Burghardt, Kyle J. Burghardt, et al.. (2012). The influence of metabolic syndrome, physical activity and genotype on catechol-O-methyl transferase promoter-region methylation in schizophrenia. The Pharmacogenomics Journal. 13(3). 264–271. 37 indexed citations
17.
Burghardt, Kyle J. & Vicki L. Ellingrod. (2012). Smoking Cessation: What to Tell Patients about Over-the-Counter Treatments. Current psychiatry. 11(1). 43–47.
18.
Weissman, Alicia M., Barcey T. Levy, Arthur J. Hartz, et al.. (2004). Pooled Analysis of Antidepressant Levels in Lactating Mothers, Breast Milk, and Nursing Infants. American Journal of Psychiatry. 161(6). 1066–1078. 220 indexed citations
19.
Ellingrod, Vicki L., et al.. (2002). Comparison of Risperidone with Olanzapine in Elderly Patients with Dementia and Psychosis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(1). 1–5. 31 indexed citations
20.
Ellingrod, Vicki L., Del D. Miller, Susan K. Schultz, Heidi J. Wehring, & Stephan Arndt. (2002). CYP2D6 polymorphisms and atypical antipsychotic weight gain. Psychiatric Genetics. 12(1). 55–58. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francisco J. Díaz Breakdown of academic impact, for papers by Winston W. Shen Breakdown of academic impact, for papers by Mong‐Liang Lu Breakdown of academic impact, for papers by Koichi Otani Breakdown of academic impact, for papers by Norio Yasui‐Furukori Breakdown of academic impact, for papers by Chad Bousman Breakdown of academic impact, for papers by Shih‐Ku Lin Breakdown of academic impact, for papers by Susan E. Shoaf Breakdown of academic impact, for papers by Steven M. Paul Breakdown of academic impact, for papers by William V. Bobo
Rankless by CCL
2026